Merus executive team visit Simcere headquarter

On May 21, 2018, the executive team of Merus lead by Dr. Ton Logtenberg, CEO of Merus visited the headquarter of Simcere.

20180523104542_7895.jpg 

This is the first time this European biotech visit Simcere since the two parties announced collaboration on the development and commercialization in China three bispecific antibodies utilizing Merus’proprietary Biclonics® technology platform in the area of immuno-oncology.

20180523104542_4525.jpg

During meeting with Simcere’s Chairman Mr Jinsheng Ren and Simcere’s scientists team, both companies exchanged information on the recent development and discussed possibility for future collaboration. They also took a tour to Simcere’s biological R&D platform.

20180523104541_2533.jpg

Dr. Logtenberg commented that besides the beautiful campus, he was also impressed with the wisdom and capability of Simcere scientist during this visit. 

 


Related News